Edition:
United Kingdom

Constellation Pharmaceuticals Inc (CNST.OQ)

CNST.OQ on NASDAQ Stock Exchange Global Select Market

5.99USD
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
$5.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,491
52-wk High
$12.21
52-wk Low
$5.58

Latest Key Developments (Source: Significant Developments)

Constellation Pharmaceuticals Reports Q3 Loss Per Share Of $0.81
Thursday, 8 Nov 2018 

Nov 8 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS ANNOUNCES THIRD-QUARTER AND NINE-MONTH 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.81.Q3 EARNINGS PER SHARE VIEW $-0.67 -- THOMSON REUTERS I/B/E/S.EXPECTS TO EVALUATE PROOF OF CONCEPT FOR CPI-1205 AND CPI-0610 PROGRAMS IN MID-2019.CONSTELLATION PHARMACEUTICALS - EXPECT CASH AS OF SEPT 30, 2018, WILL FUND PLANNED OPERATIONS INTO Q1 2020.  Full Article

Constellation Pharmaceuticals Shares Debut At $11.48, About 23 Pct Below IPO Price
Thursday, 19 Jul 2018 

July 19 (Reuters) - :CONSTELLATION PHARMACEUTICALS SHARES DEBUT AT $11.48 ON NASDAQ VERSUS IPO PRICE OF $15.00/SHARE.  Full Article

Constellation Pharmaceuticals Announces Pricing Of Initial Public Offering
Thursday, 19 Jul 2018 

July 18 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.SAYS INITIAL PUBLIC OFFERING OF 4.00 MILLION COMMON SHARES PRICED AT $15.00PER SHARE.  Full Article

Constellation Pharma Sees IPO Of 5.3 Mln Shares Priced $14-$16 Per Share
Monday, 9 Jul 2018 

July 9 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS INC - SEES IPO OF 5.3 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $14.00 AND $16.00 PER SHARE.  Full Article

Biotechs dominate filing activity

NEW YORK (IFR) - Judging by recent filing activity, biotechs are again likely to represent a large proportion of IPO activity in July.